Good Neighbor Pharmacy joins EQuIPP platform
VALLEY FORGE, Pa. — AmerisourceBergen on Wednesday announced a CMS Star measure improvement initiative for members of the Good Neighbor Pharmacy network, a group of more than 3,200 independent pharmacies across the nation.
“CMS has been evaluating health plans on Star measures for years. The shift in the healthcare industry to performance-based care has made a plan’s star rating a critical factor for the community pharmacy, especially since five of the performance measures, 48% of the total Part D star rating, are related to medication management,” stated AJ Caffentzis, SVP AmerisourceBergen. “AmerisourceBergen is committed to the success of community pharmacy and is proud to provide this critical educational initiative to our Good Neighbor Pharmacy members. This is the latest example of how AmerisourceBergen is shaping healthcare delivery.”
The CMS Star measure improvement initiative includes an agreement with Pharmacy Quality Solutions to bring EQuIPP to Good Neighbor Pharmacy members. EQuIPP (Electronic Quality Improvement Platform for Plans and Pharmacies) is a national platform for medication-related quality measurement, benchmarking and collaboration amongst health plans, prescription benefit managers and community pharmacies. EQuIPP aggregates data from multiple health plans and pharmacies to measure the quality of medication use, including non-adherence, and makes this measurement available to all participants. By serving as a neutral intermediary for quality measurement and benchmarking, EQuIPP enables pharmacies and health plans to focus on improving the quality and safety of medication use.
In addition, the improvement initiative includes a CMS Star measure educational series offered to members of Good Neighbor Pharmacy. The series, occurring in dozens of locations, imparts the latest knowledge from AmerisourceBergen experts on why Star measures are now important for community pharmacies and how pharmacies can improve their rating, passed through health plans.
A national educational roadshow is also planned in partnership with Tripp Logan, a community practice pharmacist and owner of Logan & Seiler, in Charleston, Mo. Logan is also co-developer and co-owner of MedHere Today, a medication adherence and star rating consulting group. Logan is a member of the Good Neighbor Pharmacy network and is an expert on the CMS Star measure system’s impact on community pharmacy.
“We are excited to bring EQuIPP to the thousands of pharmacies in the Good Neighbor Pharmacy,” commented David Nau, president of Pharmacy Quality Solutions. “It is clear that the leadership of Good Neighbor Pharmacy is committed to helping their pharmacies track the quality of their patient-care services and continually strive to achieve the highest standards of pharmacy quality in the country.”
Mylan buys rights to Pfizer respiratory drug
PITTSBURGH — Mylan has acquired rights to an experimental respiratory drug made by Pfizer, Mylan said Wednesday.
The drug maker said it had bought exclusive worldwide development, manufacturing and commercialization rights to the drug, which was not named, but was described as a long-acting muscarinic antagonist about to enter phase-2b, or mid-stage, clinical trials. Mylan said it would develop the drug into combination therapies and that they would use a multidose dry powder inhaler technology, also licensed from Pfizer.
"This acquisition further expands Mylan’s growing respiratory franchise, building upon the products we already have in development, such as our generic Advair program and our combination product for the treatment of chronic obstructive pulmonary disease," Mylan CEO Heather Bresch said. "By adding a novel LAMA compound to our capabilities, we will have the opportunity to bring additional combination products to market, including triple-combination therapies, and further differentiate Mylan as a leader in this important therapeutic area."
A&P inks deal with Innovatix to expand specialty pharmacy business
NEW YORK — Grocer A&P, which operates more than 300 stores across six states, has signed a three-year agreement with Innovatix, whereby it will serve as A&P’s exclusive provider of specialty pharmacy services.
“We are pleased that A&P has joined our Specialty Pharmacy Management program,” stated Innovatix president and CEO John Sganga. “Innovatix is confident that its experience collaborating with key stakeholders in the specialty market, together with its ability to manage complex purchasing data, will prove valuable as A&P grows its specialty pharmacy business.”
Through Innovatix Specialty Pharmacy Management, a turnkey and à la carte solution for retail pharmacies to expand into the specialty market, A&P will receive access to specialty medications, as well as back office services including dispensing, data management, clinical and reimbursement support and patient financial assistance.
“We are very excited about our new partnership with Innovatix to provide comprehensive Specialty Medication service to our patients,” added Robin Page, VP pharmacy at A&P. “The expertise and resources that Innovatix offers will assist us with providing product as well as full medication therapy management support for our patients.”